SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-054611
Filing Date
2013-10-21
Accepted
2013-10-21 16:28:53
Documents
1
Period of Report
2013-10-18

Document Format Files

Seq Description Document Type Size
1 WILSON F3 rrd393042.html 3  
1 WILSON F3 rrd393042.xml 3 3451
  Complete submission text file 0001181431-13-054611.txt   4977
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PUMA BIOTECHNOLOGY INC. 10880 WILSHIRE BOULEVARD, SUITE 2150 LOS ANGELES CA 90024
Business Address
WILSON TROY EDWARD (Reporting) CIK: 0001589597 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35703 | Film No.: 131161665